Bicyclic heterocycles as FGFR4 inhibitors
US11667635B2 · kind B2 · utility
4Cited by
71References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2021 |
| Grant date | Jun 6, 2023 |
| Priority date | — |
| Expiry date | May 13, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.